HEXPOL（0R7O）株式概要HEXPOL AB (publish)は、スウェーデン、その他のヨーロッパ、米国、その他のアメリカ、アジアにおいて、様々なポリマーコンパウンド、エンジニアードガスケット、シール、ホイールの開発、製造、販売を行っている。 詳細0R7O ファンダメンタル分析スノーフレーク・スコア評価5/6将来の成長1/6過去の実績1/6財務の健全性4/6配当金5/6報酬当社が推定した公正価値より45.7%で取引されている 収益は年間5.84%増加すると予測されています 5.47%の安定した配当金を支払う 同業他社や業界と比較して、良好な取引価格 リスク分析リスクチェックの結果、0R7O 、リスクは検出されなかった。すべてのリスクチェックを見る0R7O Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueSEK Current PriceSEK 77.4326.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture023b2016201920222025202620282031Revenue SEK 21.0bEarnings SEK 2.1bAdvancedSet Fair ValueView all narrativesHEXPOL AB (publ) 競合他社Croda InternationalSymbol: LSE:CRDAMarket cap: UK£4.2bElementisSymbol: LSE:ELMMarket cap: UK£863.5mTreattSymbol: LSE:TETMarket cap: UK£177.7mIofinaSymbol: AIM:IOFMarket cap: UK£92.1m価格と性能株価の高値、安値、推移の概要HEXPOL過去の株価現在の株価SEK 75.3852週高値SEK 96.8052週安値SEK 66.95ベータ0.841ヶ月の変化-5.66%3ヶ月変化-2.66%1年変化-15.40%3年間の変化-31.95%5年間の変化-28.23%IPOからの変化488.87%最新ニュースBoard Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 28Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 05 May 2026. Payment date: 11 May 2026. Payout ratio is a comfortable 74% and the cash payout ratio is 82%. Trailing yield: 5.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.9%).Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Declared Dividend • Jan 31Dividend of kr4.20 announcedDividend of kr4.20 is the same as last year. Ex-date: 5th May 2026 Payment date: 11th May 2026 Dividend yield will be 5.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (62% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 15% per year.お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.最新情報をもっと見るRecent updatesBoard Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 28Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 05 May 2026. Payment date: 11 May 2026. Payout ratio is a comfortable 74% and the cash payout ratio is 82%. Trailing yield: 5.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.9%).Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.Declared Dividend • Jan 31Dividend of kr4.20 announcedDividend of kr4.20 is the same as last year. Ex-date: 5th May 2026 Payment date: 11th May 2026 Dividend yield will be 5.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (62% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 15% per year.お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.Reported Earnings • Oct 26Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 14% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 8% per year.お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026お知らせ • Sep 22Hexpol AB (Publ) Announces President Changes for Hexpol Compounding Americas, Effective September 19, 2025HEXPOL AB (publ) has appointed Kenneth Bloom as interim President of HEXPOL Compounding Americas effective September 19, 2025. Kenneth Bloom succeeds Gary Moore, who will leave the company September 19, 2025. Kenneth Bloom will act as interim President until a permanent successor has been appointed. Kenneth has previously held the position as President of HEXPOL Compounding Americas between 2020 and 2022 and before that has some 20 years of experience within the polymer industry.Reported Earnings • Jul 19Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 16% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year.お知らせ • Jun 17HEXPOL AB (publ) to Report Q4, 2025 Results on Jan 29, 2026HEXPOL AB (publ) announced that they will report Q4, 2025 results on Jan 29, 2026お知らせ • May 01HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler.HEXPOL AB (publ) (OM:HPOL B) has signed an agreement to acquire 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler for €54 million on February 18, 2025. The acquisition price amounts to 54 MEUR on a cash and debt free basis and is funded by a combination of bank facilities and cash. The closing will take place after regulatory approvals. HEXPOL has an option toacquire the remaining shares, and the founders have an option to sell their remaining shares to HEXPOL. For the period ending December 31, 2024, KABKOM Kimya Sanayi ve Ticaret A.S. reported total revenue of €30 million. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler on April 30, 2025.Reported Earnings • Apr 27First quarter 2025 earnings released: EPS: kr1.75 (vs kr1.90 in 1Q 2024)First quarter 2025 results: EPS: kr1.75 (down from kr1.90 in 1Q 2024). Revenue: kr5.38b (up 1.3% from 1Q 2024). Net income: kr602.0m (down 8.0% from 1Q 2024). Profit margin: 11% (down from 12% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has remained flat.お知らせ • Apr 26Hexpol AB (Publ) Approves Dividend for Financial Year 2024HEXPOL AB (publ) at its AGM held on April 25, 2025, resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 4.20 per share be declared for the financial year 2024 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 29, 2025.Upcoming Dividend • Apr 21Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 28 April 2025. Payment date: 05 May 2025. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of British dividend payers (6.2%). In line with average of industry peers (4.9%).お知らせ • Apr 10HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta.HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. In line with the communication at the time of acquisition of almaak in 2022, the option to purchase the remaining 30% of almaak is now exercised. Current management will remain with the company. The transaction takes place on 9 April 2025 and will be included in the second quarter of 2025. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025.Reported Earnings • Mar 26Full year 2024 earnings released: EPS: kr6.45 (vs kr7.33 in FY 2023)Full year 2024 results: EPS: kr6.45 (down from kr7.33 in FY 2023). Revenue: kr20.4b (down 7.3% from FY 2023). Net income: kr2.22b (down 12% from FY 2023). Profit margin: 11% (in line with FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has remained flat and the company’s share price has also remained flat.Declared Dividend • Mar 12Dividend of kr4.20 announcedShareholders will receive a dividend of kr4.20. Ex-date: 28th April 2025 Payment date: 5th May 2025 Dividend yield will be 4.1%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (69% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 23% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jan 29HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025. Location: malmo Swedenお知らせ • Dec 12Hexpol Americas Announces Changes in Production Capacity and Product PortfolioHEXPOL Americas has announced changes within its product portfolio and production capacity. These changes are to optimize and create better efficiency in operations. The production site in Kennedale, Texas will be closed by the end of Q2, 2025 and all business from Kennedale will be relocated to other North American facilities. HEXPOL Americas will work closely with customers to make sure the transition is seamless. Costs associated with the closure of the production site will be accounted for in Fourth Quarter 2024. The transaction will be reported separately in Fourth Quarter 2024. HEXPOL Americas has also divested the production site in Muscle Shoals, Alabama effective immediately, to the private investment firm Karo Ventures LLC. HEXPOL Americas will work closely with Karo Ventures to make sure the transition is seamless for associates, customers and suppliers. The production site manufactured products outside of HEXPOL's core business and had an annual turnover of some 7 MUSD with a profitability level below that of the HEXPOL Group. The transaction will be reported separately in Fourth Quarter 2024, with minimal impact on the net result.お知らせ • Nov 02HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel for $86 million.HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel for $86 million on October 31, 2024. The acquisition price amounts to $86 million on a cash and debt free basis and is funded by a combination of bank facilities and cash. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel on October 31, 2024.Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: kr1.62 (vs kr1.95 in 3Q 2023)Third quarter 2024 results: EPS: kr1.62 (down from kr1.95 in 3Q 2023). Revenue: kr4.98b (down 8.9% from 3Q 2023). Net income: kr559.0m (down 17% from 3Q 2023). Profit margin: 11% (down from 12% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.お知らせ • Oct 25+ 2 more updatesHEXPOL AB (publ) to Report Q1, 2025 Results on Apr 25, 2025HEXPOL AB (publ) announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Aug 19HEXPOL AB (publ) to Report Q4, 2024 Results on Jan 28, 2025HEXPOL AB (publ) announced that they will report Q4, 2024 results on Jan 28, 2025Reported Earnings • Jul 18Second quarter 2024 earnings released: EPS: kr1.90 (vs kr1.97 in 2Q 2023)Second quarter 2024 results: EPS: kr1.90 (down from kr1.97 in 2Q 2023). Revenue: kr5.45b (down 4.8% from 2Q 2023). Net income: kr654.0m (down 3.7% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.お知らせ • Jul 01+ 1 more updateKlas Dahlberg Assumes Position of CEO of HEXPOL ABKlas Dahlberg has been appointed CEO of HEXPOL AB. He assumes his position on July 1 2024.お知らせ • Apr 27+ 1 more updateHexpol AB (Publ) Approves Dividend for the Financial Year 2023HEXPOL AB (publ) at its AGM held on April 26, 2024 resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 6.00 per share be declared for the financial year 2023 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 30, 2024.Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: kr1.90 (vs kr1.94 in 1Q 2023)First quarter 2024 results: EPS: kr1.90 (down from kr1.94 in 1Q 2023). Revenue: kr5.31b (down 11% from 1Q 2023). Net income: kr654.0m (down 2.1% from 1Q 2023). Profit margin: 12% (up from 11% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 2.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 6% per year.Upcoming Dividend • Apr 22Upcoming dividend of kr6.00 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 06 May 2024. Payout ratio is a comfortable 55% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of British dividend payers (6.0%). In line with average of industry peers (2.9%).Buy Or Sell Opportunity • Apr 17Now 21% undervaluedOver the last 90 days, the stock has risen 16% to kr132. The fair value is estimated to be kr167, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 4.3% per annum over the same time period.Reported Earnings • Mar 27Full year 2023 earnings released: EPS: kr7.33 (vs kr7.21 in FY 2022)Full year 2023 results: EPS: kr7.33 (up from kr7.21 in FY 2022). Revenue: kr22.0b (flat on FY 2022). Net income: kr2.52b (up 1.7% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 10% per year.Declared Dividend • Mar 27Dividend increased to kr6.00Dividend of kr6.00 is 67% higher than last year. Ex-date: 29th April 2024 Payment date: 6th May 2024 Dividend yield will be 4.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (55% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Mar 22Now 20% undervaluedOver the last 90 days, the stock has risen 6.5% to kr130. The fair value is estimated to be kr163, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 2.1% per annum. Earnings are also forecast to grow by 4.0% per annum over the same time period.お知らせ • Jan 27+ 2 more updatesHEXPOL AB (publ) Revises Dividend PolicyThe Board of directors of HEXPOL AB (publ) to raise the dividend policy from 25-50% to 40-60% of profit after tax.Reported Earnings • Jan 27Full year 2023 earnings released: EPS: kr7.33 (vs kr7.21 in FY 2022)Full year 2023 results: EPS: kr7.33 (up from kr7.21 in FY 2022). Revenue: kr22.0b (flat on FY 2022). Net income: kr2.52b (up 1.7% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Jan 05Now 21% undervaluedOver the last 90 days, the stock is up 27%. The fair value is estimated to be kr150, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 20%. For the next 3 years, revenue is forecast to grow by 1.3% per annum. Earnings is also forecast to grow by 2.7% per annum over the same time period.お知らせ • Dec 19+ 1 more updateHEXPOL AB (publ) Appoints Klas Dahlberg as President, Effective Latest by 1 July 2024The Board of Directors of HEXPOL AB (publ.) has appointed Klas Dahlberg as President of the company. He will take up the position latest by 1 July 2024. Klas Dahlberg currently holds the position as Head of Business Area NIBE Climate Solutions. He has been with NIBE since 2016 and he has been responsible for NIBE Climate Solutions since 2018. Prior to joining NIBE, he had a successful international career spanning over a 30-year period with the Scania group, with his last position being responsible for the division of Buses & Coaches. Klas has lived and worked in Germany for many years. He holds a M.Sc. in Engineering from Lund University, Sweden.お知らせ • Nov 14HEXPOL AB (publ) (OM:HPOL B) acquired Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg for $26.5 million.HEXPOL AB (publ) (OM:HPOL B) acquired Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg for $26.5 million on November 1, 2023. The acquisition price amounts to $26.5 million on a cash and debt free basis and is funded by a combination of cash on hand and existing bank facilities. As on November 14, 2023, Star Thermoplastic Alloys & Rubbers, Inc. reported a revenue of approximately $20 million for the year ended December 31, 2022. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg on November 1, 2023.Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr5.46b (down 7.8% from 3Q 2022). Net income: kr670.0m (up 8.9% from 3Q 2022). Profit margin: 12% (up from 10% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Sep 03HEXPOL AB (publ), Annual General Meeting, Apr 26, 2024HEXPOL AB (publ), Annual General Meeting, Apr 26, 2024.お知らせ • Sep 02+ 2 more updatesHEXPOL AB (publ) to Report Q3, 2024 Results on Oct 25, 2024HEXPOL AB (publ) announced that they will report Q3, 2024 results on Oct 25, 2024お知らせ • Sep 01+ 2 more updatesHEXPOL AB (publ) to Report Fiscal Year 2023 Results on Jan 26, 2024HEXPOL AB (publ) announced that they will report fiscal year 2023 results on Jan 26, 2024Buying Opportunity • Aug 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.0%. The fair value is estimated to be kr135, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to decline by 2.4% in 2 years. Earnings is forecast to grow by 5.4% in the next 2 years.Buying Opportunity • Jul 20Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be kr136, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 26%. Revenue is forecast to decline by 1.4% in 2 years. Earnings is forecast to grow by 6.1% in the next 2 years.Reported Earnings • Jul 20Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: kr5.73b (up 1.3% from 2Q 2022). Net income: kr679.0m (up 5.4% from 2Q 2022). Profit margin: 12% (in line with 2Q 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 7.5% decline forecast for the Chemicals industry in the United Kingdom.Buying Opportunity • Jun 09Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.2% in 2 years. Earnings is forecast to grow by 7.8% in the next 2 years.Buying Opportunity • May 24Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.5% in 2 years. Earnings is forecast to grow by 7.4% in the next 2 years.Buying Opportunity • May 04Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr147, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.5% in 2 years. Earnings is forecast to grow by 7.4% in the next 2 years.Reported Earnings • Apr 29First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: kr5.99b (up 16% from 1Q 2022). Net income: kr668.0m (up 11% from 1Q 2022). Profit margin: 11% (in line with 1Q 2022). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 2.3% growth forecast for the Chemicals industry in the United Kingdom.Upcoming Dividend • Apr 25Upcoming dividend of kr3.60 per share at 2.8% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).お知らせ • Jan 28+ 2 more updatesHEXPOL AB (publ) to Report First Half, 2023 Results on Jul 19, 2023HEXPOL AB (publ) announced that they will report first half, 2023 results on Jul 19, 2023Reported Earnings • Jan 27Full year 2022 earnings released: EPS: kr7.21 (vs kr6.85 in FY 2021)Full year 2022 results: EPS: kr7.21 (up from kr6.85 in FY 2021). Revenue: kr22.2b (up 39% from FY 2021). Net income: kr2.48b (up 5.3% from FY 2021). Profit margin: 11% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Buying Opportunity • Dec 13Now 21% undervaluedOver the last 90 days, the stock is up 20%. The fair value is estimated to be kr144, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Oct 22HEXPOL AB (publ) to Report Q4, 2022 Results on Jan 27, 2023HEXPOL AB (publ) announced that they will report Q4, 2022 results at 12:00 PM, Central European Standard Time on Jan 27, 2023Reported Earnings • Oct 21Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr5.92b (up 44% from 3Q 2021). Net income: kr615.0m (down 27% from 3Q 2021). Profit margin: 10% (down from 21% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to stay flat during the next 3 years compared to a 8.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jul 16Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: kr5.65b (up 41% from 2Q 2021). Net income: kr644.0m (up 20% from 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.3% compared to a 16% decline forecast for the industry in the United Kingdom.Reported Earnings • Apr 30First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: kr5.17b (up 36% from 1Q 2021). Net income: kr600.0m (up 12% from 1Q 2021). Profit margin: 12% (down from 14% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 18% compared to a 14% decline forecast for the industry in the United Kingdom.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Apr 22Upcoming dividend of kr6.00 per shareEligible shareholders must have bought the stock before 29 April 2022. Payment date: 05 May 2022. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.6%).Reported Earnings • Apr 08Full year 2021 earnings released: EPS: kr6.85 (vs kr4.09 in FY 2020)Full year 2021 results: EPS: kr6.85 (up from kr4.09 in FY 2020). Revenue: kr16.0b (up 19% from FY 2020). Net income: kr2.36b (up 67% from FY 2020). Profit margin: 15% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14% compared to a 15% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Jan 30Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: kr6.85 (up from kr4.09 in FY 2020). Revenue: kr16.0b (up 19% from FY 2020). Net income: kr2.36b (up 67% from FY 2020). Profit margin: 15% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 13% compared to a 3.5% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 10% per year.Buying Opportunity • Jan 18Now 21% undervaluedOver the last 90 days, the stock is up 5.4%. The fair value is estimated to be kr139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.5% per annum over the last 3 years.Board Change • Dec 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 23Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: kr4.11b (up 23% from 3Q 2020). Net income: kr841.0m (up 97% from 3Q 2020). Profit margin: 21% (up from 13% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Recent Insider Transactions • Aug 13Insider recently sold kr6.0m worth of stockOn the 10th of August, Carsten Rüter sold around 50k shares on-market at roughly kr119 per share. In the last 3 months, there was an even bigger sale from another insider worth kr33m. Insiders have been net sellers, collectively disposing of kr50m more than they bought in the last 12 months.Recent Insider Transactions • Aug 03President & CEO recently sold kr33m worth of stockOn the 29th of July, Georg Brunstam sold around 290k shares on-market at roughly kr115 per share. This was the largest sale by an insider in the last 3 months. Georg has been a seller over the last 12 months, reducing personal holdings by kr38m.Reported Earnings • Jul 18Second quarter 2021 earnings released: EPS kr1.56 (vs kr0.35 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: kr4.00b (up 58% from 2Q 2020). Net income: kr537.0m (up 340% from 2Q 2020). Profit margin: 13% (up from 4.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Reported Earnings • Apr 30First quarter 2021 earnings releasedThe company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: kr3.81b (down 8.6% from 1Q 2020). Net income: kr534.0m (up 32% from 1Q 2020). Profit margin: 14% (up from 9.7% in 1Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.Upcoming Dividend • Apr 22Upcoming dividend of kr2.30 per shareEligible shareholders must have bought the stock before 29 April 2021. Payment date: 05 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).Reported Earnings • Apr 05Full year 2020 earnings released: EPS kr4.09 (vs kr4.48 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr13.4b (down 13% from FY 2019). Net income: kr1.41b (down 8.6% from FY 2019). Profit margin: 11% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Feb 01New 90-day high: kr93.88The company is up 17% from its price of kr80.40 on 03 November 2020. The British market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr112 per share.Reported Earnings • Jan 31Full year 2020 earnings released: EPS kr4.09 (vs kr4.48 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr13.4b (down 13% from FY 2019). Net income: kr1.41b (down 8.6% from FY 2019). Profit margin: 11% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Jan 31Revenue beats expectationsRevenue exceeded analyst estimates by 0.9%. Over the next year, revenue is forecast to grow 6.1% compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Jan 13New 90-day high: kr91.80The company is up 6.0% from its price of kr86.85 on 15 October 2020. The British market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr106 per share.Recent Insider Transactions • Jan 01President & CEO recently sold kr4.9m worth of stockOn the 28th of December, Georg Brunstam sold around 55k shares on-market at roughly kr88.74 per share. This was the largest sale by an insider in the last 3 months. This was Georg's only on-market trade for the last 12 months.Is New 90 Day High Low • Dec 29New 90-day high: kr90.55The company is up 14% from its price of kr79.70 on 30 September 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr108 per share.Is New 90 Day High Low • Nov 11New 90-day high: kr89.95The company is up 43% from its price of kr63.05 on 12 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr93.56 per share.Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of kr1.29b, down 20% from the prior year. Total revenue was kr13.8b over the last 12 months, down 9.8% from the prior year.Analyst Estimate Surprise Post Earnings • Oct 25Third-quarter earnings released: Revenue misses expectationsThird-quarter revenue missed analyst estimates by 4.5% at kr3.33b. Revenue is forecast to grow 1.4% over the next year, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Oct 16New 90-day high: kr87.60The company is up 37% from its price of kr64.00 on 17 July 2020. The British market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr90.87 per share.Is New 90 Day High Low • Oct 01New 90-day high: kr81.10The company is up 18% from its price of kr69.00 on 03 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr81.52 per share.株主還元0R7OGB ChemicalsGB 市場7D1.0%4.7%1.4%1Y-15.4%8.7%19.5%株主還元を見る業界別リターン: 0R7O過去 1 年間で8.7 % の収益を上げたUK Chemicals業界を下回りました。リターン対市場: 0R7Oは、過去 1 年間で19.5 % のリターンを上げたUK市場を下回りました。価格変動Is 0R7O's price volatile compared to industry and market?0R7O volatility0R7O Average Weekly Movement3.6%Chemicals Industry Average Movement8.0%Market Average Movement5.8%10% most volatile stocks in GB Market12.0%10% least volatile stocks in GB Market3.1%安定した株価: 0R7O 、 UK市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 0R7Oの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト18934,831Klas Dahlbergwww.hexpol.comHEXPOL AB (publish)は、スウェーデン、その他のヨーロッパ、米国、その他のアメリカ、アジアにおいて、様々なポリマーコンパウンド、エンジニアードガスケット、シール、ホイールの開発、製造、販売を行っている。HEXPOL CompoundingとHEXPOL Engineered Productsの2つのセグメントで事業を展開している。HEXPOLコンパウンド事業では、HEXFLAME、HEXLIGHT、GloMoldなどのブランドで天然ゴムおよび合成ゴムコンパウンドを、Dryflex、Mediprene、Epsseal、Lifolit、Lifocorkなどのブランドで熱可塑性エラストマーコンパウンドを、RheTechブランドで熱可塑性コンパウンドを提供している。ヘクスポール・エンジニアード・プロダクツ部門は、「ジスレーブド・グミ」ブランドでガスケットやシールの完成品を、「ステラーナ」ブランドでホイールを開発している。自動車・エンジニアリング、建築・建設・土木、航空宇宙・輸送、エネルギー、消費者製品・エレクトロニクス、ケーブル・電線、石油・ガス、ローラー、農業、ホース、グラフィック制作、玩具・スポーツ・レジャー、配管業界、さらに医療機器、プレート式熱交換器、フォークリフト、キャスターホイールのメーカーにサービスを提供している。以前はHexagon Polymers ABとして知られていたが、2008年5月にHEXPOL AB（publish）に社名変更。HEXPOL AB（publ）は1893年に設立され、スウェーデンのマルメに本社を置く。もっと見るHEXPOL AB (publ) 基礎のまとめHEXPOL の収益と売上を時価総額と比較するとどうか。0R7O 基礎統計学時価総額SEK 26.45b収益（TTM）SEK 1.85b売上高(TTM)SEK 18.71b14.1xPER（株価収益率1.4xP/Sレシオ0R7O は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0R7O 損益計算書（TTM）収益SEK 18.71b売上原価SEK 14.78b売上総利益SEK 3.93bその他の費用SEK 2.09b収益SEK 1.85b直近の収益報告Mar 31, 2026次回決算日Jul 20, 2026一株当たり利益（EPS）5.37グロス・マージン21.03%純利益率9.88%有利子負債／自己資本比率29.2%0R7O の長期的なパフォーマンスは？過去の実績と比較を見る配当金5.6%現在の配当利回り78%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 17:28終値2026/05/26 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋HEXPOL AB (publ) 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関null nullABG Sundal CollierAndres Castanos-MollorBerenbergFabian WeinstockBerenberg7 その他のアナリストを表示
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 28Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 05 May 2026. Payment date: 11 May 2026. Payout ratio is a comfortable 74% and the cash payout ratio is 82%. Trailing yield: 5.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.9%).
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Declared Dividend • Jan 31Dividend of kr4.20 announcedDividend of kr4.20 is the same as last year. Ex-date: 5th May 2026 Payment date: 11th May 2026 Dividend yield will be 5.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (62% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 15% per year.
お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 28Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 05 May 2026. Payment date: 11 May 2026. Payout ratio is a comfortable 74% and the cash payout ratio is 82%. Trailing yield: 5.5%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (3.9%).
Reported Earnings • Apr 12Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
Declared Dividend • Jan 31Dividend of kr4.20 announcedDividend of kr4.20 is the same as last year. Ex-date: 5th May 2026 Payment date: 11th May 2026 Dividend yield will be 5.8%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (74% earnings payout ratio) and cash flows (62% cash payout ratio). The dividend has increased by an average of 13% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Jan 30Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024)Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 15% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 15% per year.
お知らせ • Jan 30+ 1 more updateHEXPOL AB (publ), Annual General Meeting, May 04, 2026HEXPOL AB (publ), Annual General Meeting, May 04, 2026.
Reported Earnings • Oct 26Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024)Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 14% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 8% per year.
お知らせ • Oct 24+ 2 more updatesHEXPOL AB (publ) to Report Nine Months, 2026 Results on Oct 23, 2026HEXPOL AB (publ) announced that they will report nine months, 2026 results on Oct 23, 2026
お知らせ • Sep 22Hexpol AB (Publ) Announces President Changes for Hexpol Compounding Americas, Effective September 19, 2025HEXPOL AB (publ) has appointed Kenneth Bloom as interim President of HEXPOL Compounding Americas effective September 19, 2025. Kenneth Bloom succeeds Gary Moore, who will leave the company September 19, 2025. Kenneth Bloom will act as interim President until a permanent successor has been appointed. Kenneth has previously held the position as President of HEXPOL Compounding Americas between 2020 and 2022 and before that has some 20 years of experience within the polymer industry.
Reported Earnings • Jul 19Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024)Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 16% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year.
お知らせ • Jun 17HEXPOL AB (publ) to Report Q4, 2025 Results on Jan 29, 2026HEXPOL AB (publ) announced that they will report Q4, 2025 results on Jan 29, 2026
お知らせ • May 01HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler.HEXPOL AB (publ) (OM:HPOL B) has signed an agreement to acquire 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler for €54 million on February 18, 2025. The acquisition price amounts to 54 MEUR on a cash and debt free basis and is funded by a combination of bank facilities and cash. The closing will take place after regulatory approvals. HEXPOL has an option toacquire the remaining shares, and the founders have an option to sell their remaining shares to HEXPOL. For the period ending December 31, 2024, KABKOM Kimya Sanayi ve Ticaret A.S. reported total revenue of €30 million. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler on April 30, 2025.
Reported Earnings • Apr 27First quarter 2025 earnings released: EPS: kr1.75 (vs kr1.90 in 1Q 2024)First quarter 2025 results: EPS: kr1.75 (down from kr1.90 in 1Q 2024). Revenue: kr5.38b (up 1.3% from 1Q 2024). Net income: kr602.0m (down 8.0% from 1Q 2024). Profit margin: 11% (down from 12% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has remained flat.
お知らせ • Apr 26Hexpol AB (Publ) Approves Dividend for Financial Year 2024HEXPOL AB (publ) at its AGM held on April 25, 2025, resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 4.20 per share be declared for the financial year 2024 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 29, 2025.
Upcoming Dividend • Apr 21Upcoming dividend of kr4.20 per shareEligible shareholders must have bought the stock before 28 April 2025. Payment date: 05 May 2025. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of British dividend payers (6.2%). In line with average of industry peers (4.9%).
お知らせ • Apr 10HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta.HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. In line with the communication at the time of acquisition of almaak in 2022, the option to purchase the remaining 30% of almaak is now exercised. Current management will remain with the company. The transaction takes place on 9 April 2025 and will be included in the second quarter of 2025. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025.
Reported Earnings • Mar 26Full year 2024 earnings released: EPS: kr6.45 (vs kr7.33 in FY 2023)Full year 2024 results: EPS: kr6.45 (down from kr7.33 in FY 2023). Revenue: kr20.4b (down 7.3% from FY 2023). Net income: kr2.22b (down 12% from FY 2023). Profit margin: 11% (in line with FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has remained flat and the company’s share price has also remained flat.
Declared Dividend • Mar 12Dividend of kr4.20 announcedShareholders will receive a dividend of kr4.20. Ex-date: 28th April 2025 Payment date: 5th May 2025 Dividend yield will be 4.1%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (65% earnings payout ratio) and cash flows (69% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 23% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jan 29HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025. Location: malmo Sweden
お知らせ • Dec 12Hexpol Americas Announces Changes in Production Capacity and Product PortfolioHEXPOL Americas has announced changes within its product portfolio and production capacity. These changes are to optimize and create better efficiency in operations. The production site in Kennedale, Texas will be closed by the end of Q2, 2025 and all business from Kennedale will be relocated to other North American facilities. HEXPOL Americas will work closely with customers to make sure the transition is seamless. Costs associated with the closure of the production site will be accounted for in Fourth Quarter 2024. The transaction will be reported separately in Fourth Quarter 2024. HEXPOL Americas has also divested the production site in Muscle Shoals, Alabama effective immediately, to the private investment firm Karo Ventures LLC. HEXPOL Americas will work closely with Karo Ventures to make sure the transition is seamless for associates, customers and suppliers. The production site manufactured products outside of HEXPOL's core business and had an annual turnover of some 7 MUSD with a profitability level below that of the HEXPOL Group. The transaction will be reported separately in Fourth Quarter 2024, with minimal impact on the net result.
お知らせ • Nov 02HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel for $86 million.HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel for $86 million on October 31, 2024. The acquisition price amounts to $86 million on a cash and debt free basis and is funded by a combination of bank facilities and cash. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Piedmont Resin Supply LLC from Matt Griffith and Paul Daniel on October 31, 2024.
Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: kr1.62 (vs kr1.95 in 3Q 2023)Third quarter 2024 results: EPS: kr1.62 (down from kr1.95 in 3Q 2023). Revenue: kr4.98b (down 8.9% from 3Q 2023). Net income: kr559.0m (down 17% from 3Q 2023). Profit margin: 11% (down from 12% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 2% per year and the company’s share price has also increased by 2% per year.
お知らせ • Oct 25+ 2 more updatesHEXPOL AB (publ) to Report Q1, 2025 Results on Apr 25, 2025HEXPOL AB (publ) announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Aug 19HEXPOL AB (publ) to Report Q4, 2024 Results on Jan 28, 2025HEXPOL AB (publ) announced that they will report Q4, 2024 results on Jan 28, 2025
Reported Earnings • Jul 18Second quarter 2024 earnings released: EPS: kr1.90 (vs kr1.97 in 2Q 2023)Second quarter 2024 results: EPS: kr1.90 (down from kr1.97 in 2Q 2023). Revenue: kr5.45b (down 4.8% from 2Q 2023). Net income: kr654.0m (down 3.7% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 6.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 3% per year.
お知らせ • Jul 01+ 1 more updateKlas Dahlberg Assumes Position of CEO of HEXPOL ABKlas Dahlberg has been appointed CEO of HEXPOL AB. He assumes his position on July 1 2024.
お知らせ • Apr 27+ 1 more updateHexpol AB (Publ) Approves Dividend for the Financial Year 2023HEXPOL AB (publ) at its AGM held on April 26, 2024 resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 6.00 per share be declared for the financial year 2023 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 30, 2024.
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: kr1.90 (vs kr1.94 in 1Q 2023)First quarter 2024 results: EPS: kr1.90 (down from kr1.94 in 1Q 2023). Revenue: kr5.31b (down 11% from 1Q 2023). Net income: kr654.0m (down 2.1% from 1Q 2023). Profit margin: 12% (up from 11% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 2.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 6% per year.
Upcoming Dividend • Apr 22Upcoming dividend of kr6.00 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 06 May 2024. Payout ratio is a comfortable 55% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of British dividend payers (6.0%). In line with average of industry peers (2.9%).
Buy Or Sell Opportunity • Apr 17Now 21% undervaluedOver the last 90 days, the stock has risen 16% to kr132. The fair value is estimated to be kr167, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 4.3% per annum over the same time period.
Reported Earnings • Mar 27Full year 2023 earnings released: EPS: kr7.33 (vs kr7.21 in FY 2022)Full year 2023 results: EPS: kr7.33 (up from kr7.21 in FY 2022). Revenue: kr22.0b (flat on FY 2022). Net income: kr2.52b (up 1.7% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 10% per year.
Declared Dividend • Mar 27Dividend increased to kr6.00Dividend of kr6.00 is 67% higher than last year. Ex-date: 29th April 2024 Payment date: 6th May 2024 Dividend yield will be 4.6%, which is higher than the industry average of 3.0%. Sustainability & Growth Dividend is covered by both earnings (55% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 13% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Mar 22Now 20% undervaluedOver the last 90 days, the stock has risen 6.5% to kr130. The fair value is estimated to be kr163, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 20% over the last 3 years. Earnings per share has grown by 15%. For the next 3 years, revenue is forecast to grow by 2.1% per annum. Earnings are also forecast to grow by 4.0% per annum over the same time period.
お知らせ • Jan 27+ 2 more updatesHEXPOL AB (publ) Revises Dividend PolicyThe Board of directors of HEXPOL AB (publ) to raise the dividend policy from 25-50% to 40-60% of profit after tax.
Reported Earnings • Jan 27Full year 2023 earnings released: EPS: kr7.33 (vs kr7.21 in FY 2022)Full year 2023 results: EPS: kr7.33 (up from kr7.21 in FY 2022). Revenue: kr22.0b (flat on FY 2022). Net income: kr2.52b (up 1.7% from FY 2022). Profit margin: 11% (in line with FY 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Jan 05Now 21% undervaluedOver the last 90 days, the stock is up 27%. The fair value is estimated to be kr150, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 20%. For the next 3 years, revenue is forecast to grow by 1.3% per annum. Earnings is also forecast to grow by 2.7% per annum over the same time period.
お知らせ • Dec 19+ 1 more updateHEXPOL AB (publ) Appoints Klas Dahlberg as President, Effective Latest by 1 July 2024The Board of Directors of HEXPOL AB (publ.) has appointed Klas Dahlberg as President of the company. He will take up the position latest by 1 July 2024. Klas Dahlberg currently holds the position as Head of Business Area NIBE Climate Solutions. He has been with NIBE since 2016 and he has been responsible for NIBE Climate Solutions since 2018. Prior to joining NIBE, he had a successful international career spanning over a 30-year period with the Scania group, with his last position being responsible for the division of Buses & Coaches. Klas has lived and worked in Germany for many years. He holds a M.Sc. in Engineering from Lund University, Sweden.
お知らせ • Nov 14HEXPOL AB (publ) (OM:HPOL B) acquired Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg for $26.5 million.HEXPOL AB (publ) (OM:HPOL B) acquired Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg for $26.5 million on November 1, 2023. The acquisition price amounts to $26.5 million on a cash and debt free basis and is funded by a combination of cash on hand and existing bank facilities. As on November 14, 2023, Star Thermoplastic Alloys & Rubbers, Inc. reported a revenue of approximately $20 million for the year ended December 31, 2022. HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of Star Thermoplastic Alloys & Rubbers, Inc. from Thomas A. Dieschbourg on November 1, 2023.
Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: kr5.46b (down 7.8% from 3Q 2022). Net income: kr670.0m (up 8.9% from 3Q 2022). Profit margin: 12% (up from 10% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Sep 03HEXPOL AB (publ), Annual General Meeting, Apr 26, 2024HEXPOL AB (publ), Annual General Meeting, Apr 26, 2024.
お知らせ • Sep 02+ 2 more updatesHEXPOL AB (publ) to Report Q3, 2024 Results on Oct 25, 2024HEXPOL AB (publ) announced that they will report Q3, 2024 results on Oct 25, 2024
お知らせ • Sep 01+ 2 more updatesHEXPOL AB (publ) to Report Fiscal Year 2023 Results on Jan 26, 2024HEXPOL AB (publ) announced that they will report fiscal year 2023 results on Jan 26, 2024
Buying Opportunity • Aug 08Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 8.0%. The fair value is estimated to be kr135, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to decline by 2.4% in 2 years. Earnings is forecast to grow by 5.4% in the next 2 years.
Buying Opportunity • Jul 20Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be kr136, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 26%. Revenue is forecast to decline by 1.4% in 2 years. Earnings is forecast to grow by 6.1% in the next 2 years.
Reported Earnings • Jul 20Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: kr5.73b (up 1.3% from 2Q 2022). Net income: kr679.0m (up 5.4% from 2Q 2022). Profit margin: 12% (in line with 2Q 2022). Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 7.5% decline forecast for the Chemicals industry in the United Kingdom.
Buying Opportunity • Jun 09Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.2% in 2 years. Earnings is forecast to grow by 7.8% in the next 2 years.
Buying Opportunity • May 24Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr145, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.5% in 2 years. Earnings is forecast to grow by 7.4% in the next 2 years.
Buying Opportunity • May 04Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be kr147, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 1.5% in 2 years. Earnings is forecast to grow by 7.4% in the next 2 years.
Reported Earnings • Apr 29First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: kr5.99b (up 16% from 1Q 2022). Net income: kr668.0m (up 11% from 1Q 2022). Profit margin: 11% (in line with 1Q 2022). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 2.3% growth forecast for the Chemicals industry in the United Kingdom.
Upcoming Dividend • Apr 25Upcoming dividend of kr3.60 per share at 2.8% yieldEligible shareholders must have bought the stock before 02 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 50% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).
お知らせ • Jan 28+ 2 more updatesHEXPOL AB (publ) to Report First Half, 2023 Results on Jul 19, 2023HEXPOL AB (publ) announced that they will report first half, 2023 results on Jul 19, 2023
Reported Earnings • Jan 27Full year 2022 earnings released: EPS: kr7.21 (vs kr6.85 in FY 2021)Full year 2022 results: EPS: kr7.21 (up from kr6.85 in FY 2021). Revenue: kr22.2b (up 39% from FY 2021). Net income: kr2.48b (up 5.3% from FY 2021). Profit margin: 11% (down from 15% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 1.9% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Buying Opportunity • Dec 13Now 21% undervaluedOver the last 90 days, the stock is up 20%. The fair value is estimated to be kr144, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.0% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 13% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 22HEXPOL AB (publ) to Report Q4, 2022 Results on Jan 27, 2023HEXPOL AB (publ) announced that they will report Q4, 2022 results at 12:00 PM, Central European Standard Time on Jan 27, 2023
Reported Earnings • Oct 21Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: kr5.92b (up 44% from 3Q 2021). Net income: kr615.0m (down 27% from 3Q 2021). Profit margin: 10% (down from 21% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to stay flat during the next 3 years compared to a 8.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jul 16Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: kr5.65b (up 41% from 2Q 2021). Net income: kr644.0m (up 20% from 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.3% compared to a 16% decline forecast for the industry in the United Kingdom.
Reported Earnings • Apr 30First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: kr5.17b (up 36% from 1Q 2021). Net income: kr600.0m (up 12% from 1Q 2021). Profit margin: 12% (down from 14% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 18% compared to a 14% decline forecast for the industry in the United Kingdom.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Apr 22Upcoming dividend of kr6.00 per shareEligible shareholders must have bought the stock before 29 April 2022. Payment date: 05 May 2022. Payout ratio is a comfortable 44% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.6%).
Reported Earnings • Apr 08Full year 2021 earnings released: EPS: kr6.85 (vs kr4.09 in FY 2020)Full year 2021 results: EPS: kr6.85 (up from kr4.09 in FY 2020). Revenue: kr16.0b (up 19% from FY 2020). Net income: kr2.36b (up 67% from FY 2020). Profit margin: 15% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 14% compared to a 15% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Jan 30Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: kr6.85 (up from kr4.09 in FY 2020). Revenue: kr16.0b (up 19% from FY 2020). Net income: kr2.36b (up 67% from FY 2020). Profit margin: 15% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 13% compared to a 3.5% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 10% per year.
Buying Opportunity • Jan 18Now 21% undervaluedOver the last 90 days, the stock is up 5.4%. The fair value is estimated to be kr139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 4.5% per annum over the last 3 years.
Board Change • Dec 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. Independent Director Gun Nilsson was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 23Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: kr4.11b (up 23% from 3Q 2020). Net income: kr841.0m (up 97% from 3Q 2020). Profit margin: 21% (up from 13% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Aug 13Insider recently sold kr6.0m worth of stockOn the 10th of August, Carsten Rüter sold around 50k shares on-market at roughly kr119 per share. In the last 3 months, there was an even bigger sale from another insider worth kr33m. Insiders have been net sellers, collectively disposing of kr50m more than they bought in the last 12 months.
Recent Insider Transactions • Aug 03President & CEO recently sold kr33m worth of stockOn the 29th of July, Georg Brunstam sold around 290k shares on-market at roughly kr115 per share. This was the largest sale by an insider in the last 3 months. Georg has been a seller over the last 12 months, reducing personal holdings by kr38m.
Reported Earnings • Jul 18Second quarter 2021 earnings released: EPS kr1.56 (vs kr0.35 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: kr4.00b (up 58% from 2Q 2020). Net income: kr537.0m (up 340% from 2Q 2020). Profit margin: 13% (up from 4.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 30First quarter 2021 earnings releasedThe company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: kr3.81b (down 8.6% from 1Q 2020). Net income: kr534.0m (up 32% from 1Q 2020). Profit margin: 14% (up from 9.7% in 1Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
Upcoming Dividend • Apr 22Upcoming dividend of kr2.30 per shareEligible shareholders must have bought the stock before 29 April 2021. Payment date: 05 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).
Reported Earnings • Apr 05Full year 2020 earnings released: EPS kr4.09 (vs kr4.48 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr13.4b (down 13% from FY 2019). Net income: kr1.41b (down 8.6% from FY 2019). Profit margin: 11% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Feb 01New 90-day high: kr93.88The company is up 17% from its price of kr80.40 on 03 November 2020. The British market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr112 per share.
Reported Earnings • Jan 31Full year 2020 earnings released: EPS kr4.09 (vs kr4.48 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr13.4b (down 13% from FY 2019). Net income: kr1.41b (down 8.6% from FY 2019). Profit margin: 11% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Jan 31Revenue beats expectationsRevenue exceeded analyst estimates by 0.9%. Over the next year, revenue is forecast to grow 6.1% compared to a 11% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Jan 13New 90-day high: kr91.80The company is up 6.0% from its price of kr86.85 on 15 October 2020. The British market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr106 per share.
Recent Insider Transactions • Jan 01President & CEO recently sold kr4.9m worth of stockOn the 28th of December, Georg Brunstam sold around 55k shares on-market at roughly kr88.74 per share. This was the largest sale by an insider in the last 3 months. This was Georg's only on-market trade for the last 12 months.
Is New 90 Day High Low • Dec 29New 90-day high: kr90.55The company is up 14% from its price of kr79.70 on 30 September 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr108 per share.
Is New 90 Day High Low • Nov 11New 90-day high: kr89.95The company is up 43% from its price of kr63.05 on 12 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr93.56 per share.
Reported Earnings • Oct 25Third quarter earnings releasedOver the last 12 months the company has reported total profits of kr1.29b, down 20% from the prior year. Total revenue was kr13.8b over the last 12 months, down 9.8% from the prior year.
Analyst Estimate Surprise Post Earnings • Oct 25Third-quarter earnings released: Revenue misses expectationsThird-quarter revenue missed analyst estimates by 4.5% at kr3.33b. Revenue is forecast to grow 1.4% over the next year, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Oct 16New 90-day high: kr87.60The company is up 37% from its price of kr64.00 on 17 July 2020. The British market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr90.87 per share.
Is New 90 Day High Low • Oct 01New 90-day high: kr81.10The company is up 18% from its price of kr69.00 on 03 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr81.52 per share.
